Ronsini, C.; Restaino, S.; Ludovisi, M.; Vizzielli, G.; Di Donna, M.C.; Cucinella, G.; Solazzo, M.C.; Scaffa, C.; De Franciscis, P.; Fordellone, M.;
et al. Inflammatory Indices vs. CA 125 for the Diagnosis of Early Ovarian Cancer: Evidence from a Multicenter Prospective Italian Cohort. J. Pers. Med. 2025, 15, 426.
https://doi.org/10.3390/jpm15090426
AMA Style
Ronsini C, Restaino S, Ludovisi M, Vizzielli G, Di Donna MC, Cucinella G, Solazzo MC, Scaffa C, De Franciscis P, Fordellone M,
et al. Inflammatory Indices vs. CA 125 for the Diagnosis of Early Ovarian Cancer: Evidence from a Multicenter Prospective Italian Cohort. Journal of Personalized Medicine. 2025; 15(9):426.
https://doi.org/10.3390/jpm15090426
Chicago/Turabian Style
Ronsini, Carlo, Stefano Restaino, Manuela Ludovisi, Giuseppe Vizzielli, Mariano Catello Di Donna, Giuseppe Cucinella, Maria Cristina Solazzo, Cono Scaffa, Pasquale De Franciscis, Mario Fordellone,
and et al. 2025. "Inflammatory Indices vs. CA 125 for the Diagnosis of Early Ovarian Cancer: Evidence from a Multicenter Prospective Italian Cohort" Journal of Personalized Medicine 15, no. 9: 426.
https://doi.org/10.3390/jpm15090426
APA Style
Ronsini, C., Restaino, S., Ludovisi, M., Vizzielli, G., Di Donna, M. C., Cucinella, G., Solazzo, M. C., Scaffa, C., De Franciscis, P., Fordellone, M., Cianci, S., & Chiantera, V.
(2025). Inflammatory Indices vs. CA 125 for the Diagnosis of Early Ovarian Cancer: Evidence from a Multicenter Prospective Italian Cohort. Journal of Personalized Medicine, 15(9), 426.
https://doi.org/10.3390/jpm15090426
